Table 1.
Patients characteristics, N = 100
| Characteristics | Number (%) |
|---|---|
| Age | |
| Median (years) | 40 |
| Range (years) | 22–75 |
| Pathology | |
| IDC | 91 (91%) |
| ILC and others | 9 (9%) |
| Stage | |
| I | 16 (16%) |
| II | 51 (51%) |
| III | 22 (22%) |
| IV | 2 (2%) |
| Unknown | 9 (9%) |
| Grade | |
| I | 10 (10%) |
| II | 37 (37%) |
| III | 45 (45%) |
| Unknown | 8 (8%) |
| Hormone Receptor Status | |
| ER and/or PR Positive | 77 (77%) |
| ER Positive | 77 (77%) |
| ER Negative | 22 (22%) |
| ER Unknown | 1 (1%) |
| PR Positive | 77 (77%) |
| PR Negative | 22 (22%) |
| PR Unknown | 1 (1%) |
| HER-2 Status | |
| Positive | 13 (13%) |
| Negative | 80 (80%) |
| Unknown | 7 (7%) |
| Triple-Negative | 17 (17%) |
IDC Infiltrating Ductal Carcinoma, ILC Infiltrating Lobular Carcinoma